Month: January 2025

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS MASITINIB PLATFORM Paris, January 29, 2025, 7pm CET AB Science SA (Euronext – FR0010557264 – AB) today provides an update on its masitinib platform. The webcast presentation is available on the company’s website, in the section « Press Releases »: https://www.ab-science.com/news-and-media/press-releases/ Highlights of the presentation are the following: Amyotrophic lateral sclerosisNew confirmatory study AB23005 simplified for enrolment and targeting best responders for masitinib will be initiated in line with recommendation of FDA and EMA Design validated by FDA and EMA Confirmatory study authorized by FDA Pathway to registration secured with agencies Discussion with partners facilitated First study AB10015 generated strong hypothesis on patients normal progressor and prior...

OSE Immunotherapeutics and Scienta Lab Establish Strategic Partnership to Leverage Artificial Intelligence in Precision Immunotherapy Nantes and Paris – France, January 29, 2025 – 6:00pm CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) and Scienta Lab, a leader in Artificial Intelligence (AI)-driven precision immunology, announce a strategic collaboration to harness Scienta Lab’s advanced AI platform for modeling inflammatory diseases and identifying predictive biomarkers of efficacy for immunotherapies. Under this agreement, Scienta Lab will deploy EVA, its proprietary AI-powered multimodal foundation model dedicated to translational research in immunology, to discover multimodal signatures that can pinpoint predictive biomarkers for immunotherapy in immuno-inflammation. The aim is to identify patient subtypes...

January 29, 2025Announcement no. 02 BioPorto A/S appoints new interim Chairman of the Board COPENHAGEN, DENMARK, January 29, 2025, (GLOBE NEWSWIRE) – BioPorto A/S CVR-no. 17500317 (BioPorto or Company) (CPH:BIOPOR), an in vitro diagnostics company focused on empowering the early detection of Acute Kidney Injury (AKI), today announced that Board Member Henrik Juuel will be appointed interim Chairman of the Board of Directors in BioPorto A/S as John McDonough steps down and resigns as Chair and member of the Board of Directors at the end of this month. Henrik Juuel joined the Board of Directors of BioPorto A/S in 2024 and has more than 30 years of experience from the Life Science industry. Henrik is EVP & CFO of Bavarian Nordic A/S since 2018. Henrik Juuel commented; “On behalf of the full board, I want to express our deepest gratitude...

PRESS RELEASE | January 29th 2025, 5.45pm 2024 REVENUES Thanks to its strategy of diversification, SYNERGIE continues to grow amid an uncertain economic environment and in 2024 posted sales of €3.2 billion, up +2.4%  in € m Q4 2024 Q4 2023 % Variance FY 2024 FY 2023 % Variance  International 502 483 +3.9% 1,919 1,816 +5.7%  France 317 320 -0.9% 1,265 1,293 -2.1%  Total 819 803 +2.0% 3,184 3,109 +2.4%Despite a challenging market, SYNERGIE continued to grow over the year, setting a new sales record at €3,184 million, up +2.4% on the 2023 financial year (+0.9% on a like-for-like basis). This performance was achieved with  the contribution of all the geographical regions in which the Group operates. International sales (+5,7%), which account for 60.3% of the Group’s business, were driven by an organic growth of +3.0%...

2024 turnover up by +10% Confirmation of 2024 EBITDA target after curtailment impact Launch of a transformation plan Fourth quarter down slightly -2% (+3% at constant exchange rates) to 167 million euros Energy Sales: fifth consecutive quarter growth (+12%), driven by an increase in production compared with 2023 (+6% to 1.4 TWh), despite the curtailment in Brazil during the second half of the year Services: down -14% (after eliminations) Unfavourable base effect in the Development, Construction and Equipment Procurement segment, partly offset by a further +10% rise in the Operation and Maintenance segment, taking the segment’s uninterrupted growth to nine quartersAchievement of 2024 capacity targets and growth in contract awardedCapacity in operation and under construction of 3.3 gigawatts (+14%), in line with the announced...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. QUÉBEC CITY, Jan. 29, 2025 (GLOBE NEWSWIRE) — Robex Resources Inc. (TSXV: RBX) (“Robex” or the “Company”) is pleased to announce that it has closed its previously announced “best efforts” public offering of 16,585,400 common shares of the Company (each, a “Common Share”) at a price of $2.05 per Common Share for gross proceeds of $34,000,070 (the “Offering”). All currency amounts in this news release are stated in Canadian dollars, unless otherwise indicated. The Offering was led by SCP Resource Finance LP, as bookrunner and agent (the “Agent”). The number of Common Shares sold and gross proceeds realized by the Company have been adjusted to reflect the exercise by the Agent of a portion of the over-allotment option granted to the Agent to purchase from...

Management will host a shareholder and analyst conference call on February 4, 2025 LONDON, Jan. 29, 2025 (GLOBE NEWSWIRE) — Zapp Electric Vehicles Group Limited (Nasdaq: ZAPP) (“Zapp EV” or the “Company”), owner of “Zapp”, the British electric vehicle brand on a mission to revolutionise personal urban mobility, today announced it expects to report financial results for the fiscal year 2024 prior to U.S. market hours on January 31, 2025. The release and supporting materials will be available on Zapp’s Investor Relations site. Conference Call Information Zapp will host a conference call for investors and analysts on Tuesday, February 4, 2025, at 8:00 EST / 13:00 GMT. To join the conference call by phone, participants need to register in advance using the respective link below. Upon registration, participants will receive dial-in...

NEWMARKET, Ontario, Jan. 29, 2025 (GLOBE NEWSWIRE) — AirBoss of America Corp. (TSX: BOS)(OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced that AirBoss Defense Group, AirBoss’ Manufactured Products’ (“AMP”) defense business, has received a contract through the U.S. government for the ADG Molded AirBoss Lightweight Overboot (“MALO”). This award is a 3-year IDIQ contract valued at up to US$82.3 million. Deliveries under the contract are expected to commence in the second quarter of 2025. AMP, through its defense business, has supplied overboots to the United States for over 20 years. The company held the current contract for this requirement and is pleased to have again been selected as the supplier of choice for this critical personal protective equipment. The MALO was designed to provide superior protection against chemical...